Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review ...

New research by Teva Pharmaceuticals Europe shows that 46% of generic medicines from the EU Critical List of Medicines are supplied by only one provider. This ...

Please click herefor full Prescribing Information for SELARSDI. About Teva Teva Pharmaceutical Industries Ltd.. About Alvotech Alvotech is a biotech company, founded by Robert Wessman, focused ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

Really excited to talk to you today about the 2024 performance of Teva and the lookout for 2025 ... We're also mindful of the industry dynamics, including the effect of the Inflation Reduction ...

Teva Pharmaceutical Industries' Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. Management's cautious 2025 guidance sets a low bar, likely to be ...